Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mouwasat Medical Services CoSAU:4002 +0.25%100 Return-on-Tangible-Equity is 20.98% as of Mar. 2026, which is 8% below its 10-year median of 22.78. GuruFocus rates SAU:4002 with a GF Score™ of 100/100 and a GF Value™ of ﷼109.54 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 577 Healthcare Providers & Services companies, Mouwasat Medical Services Co ranks better than 70.19% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Mouwasat Medical Services Co's annualized net income for the quarter that ended in Mar. 2026 was ﷼804 Mil. Mouwasat Medical Services Co's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ﷼3,832 Mil. Therefore, Mouwasat Medical Services Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 20.98%.
The historical rank and industry rank for Mouwasat Medical Services Co's Return-on-Tangible-Equity or its related term are showing as below:
SAU:4002'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 19.07 Med: 22.78 Max: 25.34
Current: 22.19
During the past 13 years, Mouwasat Medical Services Co's highest Return-on-Tangible-Equity was 25.34%. The lowest was 19.07%. And the median was 22.78%.
SAU:4002's Return-on-Tangible-Equity is ranked better than 70.19% of 577
companies
in the Healthcare Providers & Services industry
Industry Median: 10.13
vs SAU:4002: 22.19
Mouwasat Medical Services Co (SAU:4002) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Mouwasat Medical Services Co Return-on-Tangible-Equity Related Terms
Mouwasat Medical Services Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mouwasat Medical Services Co Return-on-Tangible-Equity Chart
SAU:4002 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Mouwasat Medical Services Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mouwasat Medical Services Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mouwasat Medical Services Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Mouwasat Medical Services Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 20.98% mean?
Mouwasat Medical Services Co (SAU:4002) has a Return-on-Tangible-Equity of 20.98% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Mouwasat Medical Services Co and its competitors. This is near median its historical median of 22.78. Over the past decade, Mouwasat Medical Services Co's Return-on-Tangible-Equity has ranged from 19.07 to 25.34. According to the industry distribution chart, Mouwasat Medical Services Co ranks #172 out of 577 companies in the Healthcare Providers & Services industry, placing it in the top 29.8%.
Is Mouwasat Medical Services Co's Return-on-Tangible-Equity too high?
Mouwasat Medical Services Co's current Return-on-Tangible-Equity of 20.98% is near median its 10-year median of 22.78. Over the past 10 years, this metric has ranged from a low of 19.07 to a high of 25.34. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.13. Mouwasat Medical Services Co's value of 20.98% is 107.1% above this industry median. Based on the distribution chart, Mouwasat Medical Services Co ranks #172 out of 577 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Mouwasat Medical Services Co has a GF Score™ of 100/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mouwasat Medical Services Co ranks #172 out of 577 companies for Return-on-Tangible-Equity. This puts Mouwasat Medical Services Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.13. Mouwasat Medical Services Co's value of 20.98% is 107.1% above this benchmark. Historically, Mouwasat Medical Services Co's own Return-on-Tangible-Equity has ranged from 19.07 to 25.34 over the past decade. While the company's 10-year median is 22.78 vs. the industry median of 10.13, Mouwasat Medical Services Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.13, based on 577 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mouwasat Medical Services Co's current Return-on-Tangible-Equity of 20.98% is 107.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Mouwasat Medical Services Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mouwasat Medical Services Co's current Return-on-Tangible-Equity is 20.98%, which is near median its own 10-year median of 22.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼109.54, compared to a current price of ﷼60.90 — trading 44.4% below its estimated fair value. The current Return-on-Tangible-Equity is 20.98%, which is near median its 10-year median of 22.78 and 107.1% above the Healthcare Providers & Services industry median of 10.13. Mouwasat Medical Services Co's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current Return-on-Tangible-Equity is 20.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?
Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued.
The current stock price of ﷼60.90 is trading 44.4% below its estimated GF Value™ of ﷼109.54.
GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:4002:
Return-on-Tangible-Equity: 20.98% (near median its 10-year median of 22.78)
GF Value™: ﷼109.54 vs. price of ﷼60.90 (44.4% below fair value)
Industry Position: 107.1% above the Healthcare Providers & Services median (#172 of 577)
No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
100GF Score
Get the complete analysis for SAU:4002
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4002 has been successfully added to your 
